Analysen von Michael Leuchten
| 11.09.23 | AstraZeneca Buy | UBS AG | |
| 05.09.23 | Novo Nordisk Sell | UBS AG | |
| 24.08.23 | Roche Neutral | UBS AG | |
| 21.08.23 | Sartorius vz. Buy | UBS AG | |
| 11.08.23 | Novo Nordisk Sell | UBS AG | |
| 11.08.23 | Bayer Buy | UBS AG | |
| 09.08.23 | Novo Nordisk Sell | UBS AG | |
| 08.08.23 | Bayer Buy | UBS AG | |
|
Werbung
|
|||
| 04.08.23 | Merck Buy | UBS AG | |
| 01.08.23 | Sanofi Neutral | UBS AG | |
| 25.07.23 | Bayer Buy | UBS AG | |
| 24.07.23 | Sartorius vz. Buy | UBS AG | |
| 20.07.23 | Bayer Buy | UBS AG | |
| 18.07.23 | Novartis Neutral | UBS AG | |
| 12.07.23 | Novo Nordisk Sell | UBS AG | |
| 12.07.23 | AstraZeneca Buy | UBS AG | |
| 04.07.23 | AstraZeneca Neutral | UBS AG | |
| 29.06.23 | Bayer Buy | UBS AG | |
| 26.06.23 | Novo Nordisk Sell | UBS AG | |
| 20.06.23 | Sartorius Stedim Biotech Buy | UBS AG | |
| 19.06.23 | AstraZeneca Neutral | UBS AG | |
| 19.06.23 | Novo Nordisk Sell | UBS AG | |
| 19.06.23 | GSK Sell | UBS AG | |
| 19.06.23 | Sartorius vz. Buy | UBS AG | |
| 16.06.23 | Sartorius vz. Buy | UBS AG | |
| 16.06.23 | Merck Buy | UBS AG | |
| 15.06.23 | Roche Neutral | UBS AG | |
| 15.06.23 | Novartis Neutral | UBS AG | |
| 13.06.23 | Sanofi Neutral | UBS AG | |
| 12.06.23 | Novo Nordisk Sell | UBS AG | |
| 05.06.23 | AstraZeneca Neutral | UBS AG | |
| 05.06.23 | Novartis Neutral | UBS AG | |
| 26.05.23 | Novo Nordisk Sell | UBS AG | |
| 22.05.23 | Sanofi Neutral | UBS AG | |
| 18.05.23 | AstraZeneca Neutral | UBS AG | |
| 18.05.23 | Novartis Neutral | UBS AG | |
| 16.05.23 | Bayer Buy | UBS AG | |
| 12.05.23 | Bayer Buy | UBS AG | |
| 11.05.23 | Merck Buy | UBS AG | |
| 04.05.23 | Sartorius vz. Buy | UBS AG | |
| 04.05.23 | Novo Nordisk Sell | UBS AG | |
| 02.05.23 | Sartorius vz. Buy | UBS AG | |
| 28.04.23 | Novo Nordisk Sell | UBS AG | |
| 27.04.23 | AstraZeneca Neutral | UBS AG | |
| 27.04.23 | Sanofi Neutral | UBS AG | |
| 26.04.23 | GSK Sell | UBS AG | |
| 21.04.23 | Sartorius vz. Buy | UBS AG | |
| 14.04.23 | Novo Nordisk Sell | UBS AG | |
| 14.04.23 | Sartorius vz. Buy | UBS AG | |
| 30.03.23 | Sanofi Neutral | UBS AG | |